Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

J&J to withdraw from pramlintide collaboration; exendin update

March 4, 1998

Phase I results reported for alpha-gal in Fabry's disease

March 4, 1998

Ongoing clinical trials of Topiglan confirm positive early results

March 3, 1998

Vitamin C protects blood vessels in diabetic patients

March 3, 1998

Takeda in negotiations with potential marketing partner for pioglitazone

March 2, 1998

S-8921: specific inhibitor of ileal bile acid transport for hypercholesterolemia

March 2, 1998

ProLease formulation of erythropoietin covered by U.S. patent

Feb. 27, 1998

Development candidate selected by Fujisawa from ACAT inhibitor series

Feb. 27, 1998

Noven and Novartis to collaborate on Vivelle

Feb. 27, 1998

Xenical scheduled for FDA advisory panel review

Feb. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...